ConductScience.org, home

Paper33209651

Nanoformulation enhances anti-angiogenic efficacy of tunicamycin.

Banerjee A and 3 others. Transl Cancer Res, 2013. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Nanoformulation enhances anti-angiogenic efficacy of tunicamycin. Papers, record 33209651. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33209651

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoformulation enhances anti-angiogenic efficacy of tunicamycin.
PubMed
Journal
Transl Cancer Res
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2020-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Banerjee AAditi
2Johnson KTKaren T
3Banerjee IAIpsita A
4Banerjee DKDipak K

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P20 RR011126NCRR NIH HHSUnited StatesP20RR011126PubMed

Source NIH RePORTER

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117890669VEGF: an essential mediator of both angiogenesis and endochondral ossification.J Dent Res2007https://conductscience.org/library/papers/17890669PubMed
22673531How does extracellular matrix control capillary morphogenesis?Cell1989https://conductscience.org/library/papers/2673531PubMed
322936838Balancing life with glycoconjugates: monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman Spectroscopy.Pure Appl Chem2012https://conductscience.org/library/papers/22936838PubMed
423123313Biological applications of peptides nanotubes: an overview.Peptides2013https://conductscience.org/library/papers/23123313PubMed
522488097Development of a novel composite material with carbon nanotubes assisted by self-assembled peptides designed in conjunction with β-sheet formation.J Pharm Sci2012https://conductscience.org/library/papers/22488097PubMed
611667380Scandium Trifluoromethanesulfonate as an Extremely Active Lewis Acid Catalyst in Acylation of Alcohols with Acid Anhydrides and Mixed Anhydrides.J Org Chem1996https://conductscience.org/library/papers/11667380PubMed
721942498Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.ACS Nano2011https://conductscience.org/library/papers/21942498PubMed
810647931The hallmarks of cancer.Cell2000https://conductscience.org/library/papers/10647931PubMed
923261560Self-assembling peptide assemblies bound to ZnS nanoparticles and their interactions with mammalian cells.Colloids Surf B Biointerfaces2013https://conductscience.org/library/papers/23261560PubMed
103927288Endothelial cells from bovine adrenal medulla develop capillary-like growth patterns in culture.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3927288PubMed
1121413815Iridium-catalyzed oxidative methyl esterification of primary alcohols and diols with methanol.J Org Chem2011https://conductscience.org/library/papers/21413815PubMed
127690465A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis.Nature1993https://conductscience.org/library/papers/7690465PubMed
1317929329Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.J Pept Sci2008https://conductscience.org/library/papers/17929329PubMed
1422705199Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells.Biomaterials2012https://conductscience.org/library/papers/22705199PubMed
1519908441Multifunctional nano-micelles formed by amphiphilic gold-polycaprolactone-methoxy poly(ethylene glycol) (Au-PCL-MPEG) nanoparticles for potential drug delivery applications.J Nanosci Nanotechnol2009https://conductscience.org/library/papers/19908441PubMed
1617890668Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.J Dent Res2007https://conductscience.org/library/papers/17890668PubMed
1714646261-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells.J Biol Chem1992https://conductscience.org/library/papers/1464626PubMed
181309501Functional and morphological changes induced by tunicamycin in dividing and confluent endothelial cells.Exp Cell Res1992https://conductscience.org/library/papers/1309501PubMed
197540952The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.Cancer Res1995https://conductscience.org/library/papers/7540952PubMed
2022326428N-glycans in cell survival and death: cross-talk between glycosyltransferases.Biochim Biophys Acta2012https://conductscience.org/library/papers/22326428PubMed

See all 66 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
38561794Resolvin D1 alleviates apoptosis triggered by endoplasmic reticulum stress in IPEC-J2 cells.BMC Vet Res2024https://conductscience.org/library/papers/38561794PubMed
38474359Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.Cells2024https://conductscience.org/library/papers/38474359PubMed
38362162BIRTH OF A GLYCOTHERAPY FOR BREAST CANCER.Trends Carbohydr Res2023https://conductscience.org/library/papers/38362162PubMed
35454076Glycotherapy: A New Paradigm in Breast Cancer Research.Biomolecules2022https://conductscience.org/library/papers/35454076PubMed
34477507Gold Nanoparticles in Triple-Negative Breast Cancer Therapeutics.Curr Med Chem2023https://conductscience.org/library/papers/34477507PubMed
32829416The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.Glycobiology2020https://conductscience.org/library/papers/32829416PubMed
25408354N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic.Adv Exp Med Biol2015https://conductscience.org/library/papers/25408354PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33209651

GET https://conductscience.org/api/papers/v1/33209651/references?page=2